Douglas Loe
Stock Analyst at Leede Financial
(4.62)
# 865
Out of 4,429 analysts
152
Total ratings
47%
Success rate
21.5%
Average return
Main Sectors:
Stocks Rated by Douglas Loe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: MSCL Satellos Bioscience Inc. | Maintained: Buy | $22.67 | $8.15 | +178.17% | 3 | Mar 11, 2026 | |
| TSXV: PINK Perimeter Medical Imaging AI, Inc. | Reiterated: Buy | $3.00 | $0.295 | +916.95% | 3 | Mar 8, 2026 | |
| TSXV: NSCI Nanalysis Scientific Corp. | Maintained: Buy | $0.50 | $0.12 | +316.67% | 1 | Nov 27, 2025 | |
| ONCY Oncolytics Biotech | Maintained: Buy | $8.5 → $4 | $0.96 | +316.67% | 18 | Nov 25, 2025 | |
| TSX: CRDL Cardiol Therapeutics Inc. | Maintained: Buy | $6.38 → $15.59 | $1.51 | +935.62% | 5 | Aug 8, 2025 | |
| PMN ProMIS Neurosciences | Maintained: Buy | n/a | $10.54 | - | 2 | Jul 22, 2025 | |
| TSX: DR Medical Facilities Corporation | Maintained: Buy | $4.50 → $15.50 | $17.82 | n/a | 7 | Aug 7, 2024 | |
| TSX: SVA Sernova Biotherapeutics Inc | Maintained: Buy | $3.30 → $4.68 | $0.15 | n/a | 9 | Jun 30, 2023 | |
| TSX: EXE Extendicare Inc. | Maintained: Hold | $8.25 → $7.00 | $33.84 | n/a | 13 | May 8, 2023 | |
| IMVIF IMV Inc. | Reiterated: Buy | $7.41 → $42 | $0.000001 | n/a | 18 | Apr 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.75 → $0.25 | $0.015 | n/a | 3 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.99 → $0.11 | $2.38 | n/a | 12 | Aug 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.53 | $0.000001 | n/a | 13 | Aug 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.00 | $3.24 | n/a | 12 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $27.00 → $29.00 | $43.10 | n/a | 4 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.00 | $16.33 | n/a | 17 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37.50 | $9.60 | n/a | 6 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.000001 | n/a | 2 | Jun 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $34 → $1 | $4.55 | n/a | 4 | Oct 7, 2019 |
Satellos Bioscience Inc.
Mar 11, 2026
Maintained: Buy
Price Target: $22.67
Current: $8.15
Upside: +178.17%
Perimeter Medical Imaging AI, Inc.
Mar 8, 2026
Reiterated: Buy
Price Target: $3.00
Current: $0.295
Upside: +916.95%
Nanalysis Scientific Corp.
Nov 27, 2025
Maintained: Buy
Price Target: $0.50
Current: $0.12
Upside: +316.67%
Oncolytics Biotech
Nov 25, 2025
Maintained: Buy
Price Target: $8.5 → $4
Current: $0.96
Upside: +316.67%
Cardiol Therapeutics Inc.
Aug 8, 2025
Maintained: Buy
Price Target: $6.38 → $15.59
Current: $1.51
Upside: +935.62%
ProMIS Neurosciences
Jul 22, 2025
Maintained: Buy
Price Target: n/a
Current: $10.54
Upside: -
Medical Facilities Corporation
Aug 7, 2024
Maintained: Buy
Price Target: $4.50 → $15.50
Current: $17.82
Upside: n/a
Sernova Biotherapeutics Inc
Jun 30, 2023
Maintained: Buy
Price Target: $3.30 → $4.68
Current: $0.15
Upside: n/a
Extendicare Inc.
May 8, 2023
Maintained: Hold
Price Target: $8.25 → $7.00
Current: $33.84
Upside: n/a
IMV Inc.
Apr 12, 2022
Reiterated: Buy
Price Target: $7.41 → $42
Current: $0.000001
Upside: n/a
Feb 28, 2022
Maintained: Hold
Price Target: $2.75 → $0.25
Current: $0.015
Upside: n/a
Aug 31, 2020
Downgraded: Sell
Price Target: $0.99 → $0.11
Current: $2.38
Upside: n/a
Aug 27, 2020
Maintained: Buy
Price Target: $3.53
Current: $0.000001
Upside: n/a
Aug 14, 2020
Maintained: Buy
Price Target: $7.00
Current: $3.24
Upside: n/a
Aug 14, 2020
Maintained: Hold
Price Target: $27.00 → $29.00
Current: $43.10
Upside: n/a
Aug 13, 2020
Maintained: Buy
Price Target: $3.00
Current: $16.33
Upside: n/a
Aug 7, 2020
Maintained: Buy
Price Target: $37.50
Current: $9.60
Upside: n/a
Jun 16, 2020
Maintained: Buy
Price Target: n/a
Current: $0.000001
Upside: n/a
Oct 7, 2019
Downgraded: Hold
Price Target: $34 → $1
Current: $4.55
Upside: n/a